Monroe Capital Supports Olympus Partners' Acquisition of PAI Pharma
Portfolio Pulse from
Monroe Capital LLC has acted as a joint lead arranger in providing a senior credit facility to support Olympus Partners' acquisition of PAI Pharma, a prominent US-based oral generic liquids manufacturer. PAI, founded in 1968 and located in Greenville, SC, is known for its extensive portfolio of generic oral liquid medicines serving various healthcare sectors.
April 08, 2025 | 10:15 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Olympus Partners acquires PAI Pharma, strengthening its position in the generic oral liquid medicines market through strategic financing from Monroe Capital.
The acquisition represents a strategic expansion for Olympus Partners, potentially increasing its market value and diversifying its pharmaceutical manufacturing portfolio.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 70